Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase

Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase

US Patent 9776991 · Granted Oct 3, 2017

Estimated economic value: $8,333,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof wi2024
Isoxazolidines as RIPK1 inhibitors and use thereof2024
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2021
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjug2020
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2020
Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists2020
Compounds as peptidic GLP1/glucagon/GIP receptor agonists2019
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2019
Functionalized Exendin-4 derivatives2019
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2019
Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonist2018
Fused pyrroledicarboxamides and their use as pharmaceuticals2018